Corona T, Cervantes-Arriaga A, Velásquez-Pérez L, Rodríguez-Violante M

Idioma: Ingles.
Referencias bibliográficas: 8
Paginas: 176-180
Archivo PDF: 62.06 Kb.

RESUMEN

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Siemers E, Reddy V. Profile of patients enrolled in a new movement disorder clinic. Mov Disord. 1991;6:336-41.

2. Poon LH, Lee AJ, Chiao TB, Kang GA, Heath S, Glass GA. Pharmacist’s role in a Parkinson’s disease and movement disorder clinic. Am J Health Syst Pharm. 2012;69:518-20.

3. Yssel J, Casey E, O’Rourke K, Magennis B, Lynch T. The role of a movement disorders clinic. Ir Med. 2012;105:57-9.

4. Rochow SB, Blackwell AD, Brown VJ. Quality of life in Parkinson’s disease: movement disorders clinic vs general medical clinic--a comparative study. Scott Med J. 2005;50:18-20.

5. Müller T, Voss B, Hellwig K, Josef Sten F, Schulte T, Przuntek H. Treatment benefit and daily drug costs associated with treating Parkinson’s disease in a Parkinson’s disease clinic. CNS Drugs. 2004;18:105-11.

6. Meeuwsen EJ, Melis RJ, Van Der Aa GC, et al. Effectiveness of dementia follow-up care by memory clinics or general practitioners: a randomised controlled trial. BMJ. 2012;344:e3086.

7. Habibi M, Kuttab HM. Management of multiple sclerosis and the integration of related specialty pharmacy programs within health systems. Am J Health Syst Pharm. 2016;73:811-19.

8. Louis ED, Ferreira JJ. How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor. Mov Disord. 2010;25:534-41.